PubMed Health⌕ Search

PubMed · 8310429

Managed care programs: an employer perspective.

Abstract

Throughout the 1980s, employers made many health care benefit plan modifications that were directed toward containing costs. This chapter discusses potential managed care program changes that may occur in the coming years. Specifically reviewed are partnerships between employers and managed care entities; possible features of the next generation of managed are plans; and dimensions of a cost-benefit analysis that employers could use to gauge the cost-effectiveness of future plan changes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M S Carroll. 1993. Managed care programs: an employer perspective.. https://pubmed.ncbi.nlm.nih.gov/8310429/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Evidence rather than costs must guide use of the implantable cardioverter defibrillator.

Randomized controlled trials have shown superior survival rates with implantable cardioverter defibrillators (ICDs) compared with antiarrhythmic drugs in survivors of cardiac arrest and life-threatening ventricular tachyarrhythmias, as well as in high-risk patients with ischemic heart disease and inducible ventricular tachycardia (VT). Current defibrillators are small and implanted with techniques similar to standard pacemakers. They provide high-energy shocks for ventricular fibrillation (VF) and rapid VT, antitachycardia pacing for monomorphic VT, and antibradycardia pacing. Limited evidence suggests that ICD therapy is cost-effective when compared with other widely accepted treatments. The use of ICDs is likely to continue to expand in the future. Ongoing clinical trials will define further prophylactic indications of the ICD and clarify its cost-effectiveness ratio in different clinical settings.

Cost-Benefit Analysis↗